Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 BRL | 0.00% | -2.74% | -45.38% |
02-28 | Transcript : Kora Saúde Participações S.A., Q4 2023 Earnings Call, Feb 28, 2024 | |
02-27 | Kora Saúde Participações S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-45.38% | 106M | - | ||
-19.34% | 16.41B | B+ | ||
+5.41% | 12.64B | B | ||
+4.64% | 11.75B | B+ | ||
+2.89% | 10.04B | B+ | ||
+29.17% | 8.68B | B | ||
-2.49% | 7.68B | A- | ||
+8.59% | 7.08B | D | ||
+4.93% | 6.65B | B- | ||
+44.78% | 4.46B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- KRSA3 Stock
- Ratings Kora Saúde Participações S.A.